172 related articles for article (PubMed ID: 34601503)
21. Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides.
Morganti M; Coronnello M; Caciagli B; Biondi C; Quattrone A; Capaccioli S; Mazzei T; Mini E
Anticancer Drugs; 2000 Apr; 11(4):285-94. PubMed ID: 10898545
[TBL] [Abstract][Full Text] [Related]
22. Increased dihydrofolate reductase activity in methotrexate-resistant human promyelocytic-leukaemia (HL-60) cells. Lack of correlation between increased activity and overproduction.
Dedhar S; Hartley D; Goldie JH
Biochem J; 1985 Feb; 225(3):609-17. PubMed ID: 3856428
[TBL] [Abstract][Full Text] [Related]
23. Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy.
Domin BA; Grill SP; Cheng Y
Cancer Res; 1983 May; 43(5):2155-8. PubMed ID: 6831441
[TBL] [Abstract][Full Text] [Related]
24. Differential alterations of dihydrofolate reductase gene in human leukemia cell lines made resistant to various folate analogues.
Miyachi H; Takemura Y; Kobayashi H; Ando K; Ando Y
Jpn J Cancer Res; 1993 Jan; 84(1):9-12. PubMed ID: 8449831
[TBL] [Abstract][Full Text] [Related]
25. Dihydrofolate reductase transcript level is not suitable for methotrexate-resistance prediction in choriocarcinoma cell line.
Han B; Xiang Y; Wang Y; Wang Z; Zhang H; Huang S
Int J Gynecol Cancer; 2010 Oct; 20(7):1259-63. PubMed ID: 21495249
[TBL] [Abstract][Full Text] [Related]
26. Maintenance of differential methotrexate toxicity between cells expressing drug-resistant and wild-type dihydrofolate reductase activities in the presence of nucleosides through nucleoside transport inhibition.
Warlick CA; Sweeney CL; McIvor RS
Biochem Pharmacol; 2000 Jan; 59(2):141-51. PubMed ID: 10810448
[TBL] [Abstract][Full Text] [Related]
27. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
Kündig C; Leblanc E; Papadopoulou B; Ouellette M
Nucleic Acids Res; 1999 Sep; 27(18):3653-9. PubMed ID: 10471733
[TBL] [Abstract][Full Text] [Related]
28. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
Chen G; Wright JE; Rosowsky A
Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate exacerbates tumor progression in a murine model of chronic myeloid leukemia.
Sweeney CL; Diers MD; Frandsen JL; Gunther R; Verfaillie CM; McIvor RS
J Pharmacol Exp Ther; 2002 Mar; 300(3):1075-84. PubMed ID: 11861818
[TBL] [Abstract][Full Text] [Related]
30. Efficient protection from methotrexate toxicity and selection of transduced human hematopoietic cells following gene transfer of dihydrofolate reductase mutants.
Meisel R; Bardenheuer W; Strehblow C; Sorg UR; Elmaagacli A; Seeber S; Flasshove M; Moritz T
Exp Hematol; 2003 Dec; 31(12):1215-22. PubMed ID: 14662327
[TBL] [Abstract][Full Text] [Related]
31. Dihydrofolate reductase activity in adriamycin and methotrexate sensitive and resistant P388 leukemia cells.
Mandelbaum-Shavit F; Ramu A
Cell Biol Int Rep; 1987 May; 11(5):389-96. PubMed ID: 3607890
[TBL] [Abstract][Full Text] [Related]
32. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
[TBL] [Abstract][Full Text] [Related]
33. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
Vinh DB; McIvor RS
J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
[TBL] [Abstract][Full Text] [Related]
34. Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro.
Chu E; Takimoto CH; Voeller D; Grem JL; Allegra CJ
Biochemistry; 1993 May; 32(18):4756-60. PubMed ID: 8490020
[TBL] [Abstract][Full Text] [Related]
35. Changes in enzyme activity and expression of DHFR of Toxoplasma gondii by antifolates.
Baek EJ; Nam HW
Korean J Parasitol; 1998 Sep; 36(3):191-8. PubMed ID: 9755590
[TBL] [Abstract][Full Text] [Related]
36. Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductase.
Mareya SM; Sorrentino BP; Blakley RL
Cancer Gene Ther; 1998; 5(4):225-35. PubMed ID: 9694074
[TBL] [Abstract][Full Text] [Related]
37. Regulation of dihydrofolate reductase in human breast cancer cells and in mutant hamster cells transfected with a human dihydrofolate reductase minigene.
Cowan KH; Goldsmith ME; Ricciardone MD; Levine R; Rubalcaba E; Jolivet J
Mol Pharmacol; 1986 Jul; 30(1):69-76. PubMed ID: 3724746
[TBL] [Abstract][Full Text] [Related]
38. Investigation on inhibitory effect of folic acid on methotrexate-induced epithelial-mesenchymal transition focusing on dihydrofolate reductase.
Kawami M; Honda N; Hara T; Yumoto R; Takano M
Drug Metab Pharmacokinet; 2019 Dec; 34(6):396-399. PubMed ID: 31601464
[TBL] [Abstract][Full Text] [Related]
39. Resistance mechanisms to methotrexate in tumors.
Bertino JR; Göker E; Gorlick R; Li WW; Banerjee D
Stem Cells; 1996 Jan; 14(1):5-9. PubMed ID: 8820944
[TBL] [Abstract][Full Text] [Related]
40. Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum.
Bhattacharya A; Leprohon P; Ouellette M
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009377. PubMed ID: 33905412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
